Announcing the Winners of The French-American Entrepreneurship Award (FAEA)
Hypercell Technologies has developed a proprietary point-of-care diagnostic technology platform that is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment.
- Hypercell Technologies has developed a proprietary point-of-care diagnostic technology platform that is as accurate as the gold standard PCR, 10x faster, and without expensive lab equipment.
- Hypercell allows the detection of biological contaminants in the food chain - from production to transformation - quickly, early, frequently and with precision.
- This is a great honor that will give us even more motivation to pursue our project with energy and determination”.
- Jonathan Thorn (Co-founder & CEO, WALTER) and Guillaume Charvon, (Co-founder & Chairman, WALTER) said: “We were thrilled to participate in the FAEA.